Network Insights Methodology Whitepaper Get Access

FDA

ORG Government / Drug and Medical Device Regulation Momentum 60.4ML Momentum Score (0-100). Weighted composite of 9 features: mention velocity, article breadth, relationship density, deal context, recency, market cap, enrichment completeness, mention concentration, entity type. CRITICALPSI regime classification. QUIET (<0.3): baseline activity. NORMAL (0.3-0.5): typical deal flow. ELEVATED (0.5-0.7): above-average signals. HIGH (0.7-0.85): significant activity. EXTREME (>0.85): exceptional signal concentration. Primary: Spectral Shift

FDA (6,900 employees, $6.5B budget) regulates drugs, devices, and food products representing 20% of US consumer spending. In the past week, approved first HDV chronic infection treatment, issued draft guidance accelerating cell and gene therapies, and launched food chemical safety reassessment program.

-0.35
PSI ScorePlocamium Signal Index - composite z-score from 5 orthogonal signals: news frequency, targeted sentiment, graph centrality, regulatory filings, and clinical trial activity.
60.4
MomentumML Momentum Score (0-100). Weighted composite of 9 features including mention velocity, article breadth, deal context, and relationship density. Retrained weekly.
1%
ConfidenceSignal confidence - percentage of PSI sub-signals with sufficient data (30+ observations). Higher confidence means the PSI score is based on more complete data.
49
ConnectionsDegree centrality - number of unique entities this entity co-occurs with in news signals and articles. Higher = more connected in the intelligence network.
FDA is getting less coverage than expected — the market may be ignoring a developing story (primary driver: Attention Cascade).
Connected Entities
White House PlocamiumAI United States HHS AstraZeneca Dr. WASHINGTON Robert F. Kennedy Jr. CMS China RFK Jr. Eli Lilly Pfizer Americans Europe
Watch This Entity
PSI Intelligence
30-Day Trend
2026-05-13 2026-06-12 49 0 Degree Mentions
Signal Decomposition
Attention Cascade
-0.385
Narrative Drift
0.000
Spectral Shift
333.584
Sentiment-Momentum Divergence
0.000
Source Concentration
0.755
Signal
FDA is getting less coverage than expected — the market may be ignoring a developing story (primary driver: Attention Cascade).
Driver
Ranked #10 of 10 in Government — in line with sector peers. PSI stable vs yesterday (-1.00). Confidence: 63% (entity has limited history, score is shrunk toward sector prior).
Action
Baseline conditions. Continue standard monitoring cadence.
Peer Comparison
10 of 10
Sector Rank
+0.00
Peer Z-Score
0%
Sector Percentile
Network Analysis
49 Degree Centrality
Ego Network (top connections)
White House (weight 48.0)PlocamiumAI (weight 43.0)United States (weight 43.0)HHS (weight 35.0)AstraZeneca (weight 29.0)Dr. (weight 28.0)WASHINGTON (weight 25.0)Robert F. Kennedy Jr. (weight 24.0) White HousePlocamiumAIUnited StatesHHSAstraZenecaDr.WASHINGTONRobert F. Kenned… FDA (degree 49) FDA
Centrality History
2026-05-13 2026-06-12 49 0 Degree Mentions
EntityWeight StatusFirst Seen
White House 48 STABLE
PlocamiumAI 43 NEW
United States 43 STABLE
HHS 35 STABLE
AstraZeneca 29 NEW
Dr. 28 STABLE
WASHINGTON 25 STABLE
Robert F. Kennedy Jr. 24 NEW
CMS 17 STABLE
China 15 STABLE
RFK Jr. 15 NEW
Eli Lilly 14 NEW
Pfizer 14 STABLE
Americans 13 NEW
Europe 12 STABLE
Sanofi 12 NEW
President 12 STABLE
CEO 10 STABLE
AP 9 STABLE
Reuters 9 STABLE
U.S. Department of Health and Human Services 9 NEW
Supreme Court 8 STABLE
Senate 7 NEW
Merck 7 STABLE
Donald Trump 6 STABLE
Florida 5 NEW
Iran 5 STABLE
GOP 5 STABLE
CDC 5 STABLE
Alphabet 5 STABLE
Article Coverage (0)
DateLaneTitle
No Plocamium-authored coverage yet. This entity surfaces in upstream signals (news, filings, trials) but has not yet been a primary subject of a published article. Watch this entity to be alerted when one is published.

Request Access

Full PSI intelligence, network analysis, EDGAR filings, and predicted links require an access token.

Data as of 2026-06-12 ← Intelligence Network